The J&J vaccine was developed with stem cells. Thats caused confusion and division among Catholics. – OregonLive

Questions about whether the Johnson & Johnson COVID-19 vaccine is morally acceptable to observant Catholics due to concerns over use of fetal stem cells in its development have brought the deep divisions within the Catholic Church into public view. On Feb. 26, the Roman Catholic Archdiocese of New Orleans released a statement saying that the Johnson & Johnson vaccine is morally compromised as it uses the abortion-derived cell line in development and production of the vaccine as well as the testing

Read more
Adipose-derived Stem Cell Overview Market Trend, Growth, Size, Forecast, Key Players and Competitive Landscape Research Report by2027 The Courier -…

Adipose-derived stem cells are mesenchymal stem cells obtained from adult fat tissues during various surgical interventions such as breast reduction, liposuction, or abdominoplasty. Adipose-derived stem cells (ADSCs) possess the ability to proliferate into numerous cell lineages such as chondrocytes, adipocytes, and others. Owing to this property, these multipotent stem cells can substitute bone marrow as a rich source of stem cells

Read more
Rheumatoid Arthritis Stem Cell Therapy Market Predicted to Witness Surge in the Near Future 2018 to 2028 KSU | The Sentinel Newspaper – KSU | The…

The research report focuses on Rheumatoid Arthritis Stem Cell Therapy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018 to 2028 The study covers significant data which makes the research document a handy resource for managers, analysts, industry experts and other key people get ready-to-access and self-analyzed study along with graphs and tables to help understand market trends, drivers and market challenges.

Read more
Super-resolution system microscopy can reveal pluripotency and differentiation of live stem cells – News-Medical.net

A new super-resolution system microscopy can assess the pluripotency and differentiation of live stem cells, spearheading a new era in stem-cell research and systems biology. This technology can help in cancer research and development of treatments You might have heard about "stem cells" in the news or in popular science documentaries and wondered if they could one day help you or a loved one treat an injury or a serious disease. Indeed, since their initial discovery in the 1960s there has been a growing interest in research and treatments in this field.

Read more
New multi-faculty Centre for Cell Therapy Translation gives UCalgary skin in the game for regenerative medicine research – UCalgary News

When most people think of cell regeneration and the medical treatments this technology enables, their minds usually go directly to skin cell regeneration for burns and other severe injuries. But regenerative medicine goes far beyond skin grafts. Regenerative medicinecovers everything from stem cell therapy to cell reprogramming and gene editing, and holds great promise for the treatment of conditions from diabetes to Parkinsons disease.

Read more
Policymakers urged to extend the 14-day limit on embryo research – BioNews

8 March 2021 The 14-day limit on culturing human embryos in the lab should be extended, according to an international group of researchers. Scientists, clinicians and ethicists from the US, UK, Netherlands and China have called on policymakers, including the International Society for Stem Cell Research (ISSCR), to provide a cautious framework for culturing human embryos beyond 14 days

Read more
The Sacramento Business Journal announced that Cate Dyer, CEO, and founder of StemExpress, has been selected as one of SBJ’s 2021 Most Admired CEOs -…

SACRAMENTO, Calif., March 9, 2021 /PRNewswire/ --In 2010, Cate Dyer founded StemExpress to improve lives by accelerating scientific research focused on discovering new treatments and cures for significant medical conditions. Through our state-of-the-art stem cell collection centers and our expansive global network of hospital and clinical partners, StemExpress continues to play a pivotal role in medical research, clinical trials, commercialization of disease-specific treatment, cell and gene therapies, and precision and regenerative medicine. Our broad network of healthcare partnerships includes over 50 hospitals in Europe as well as 3 US healthcare systems that encompass 31 hospitals, 35 outpatient facilities, and 20 individual practices.

Read more